Sign In
Buy TEVA
$34.72
+0.290 (+0.84%)
At Close: Aug 05, 2026
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
07:30am, Monday, 01'st Nov 2021
Teva Pharmaceuticals Industries Ltd (NYSE: TEVA) announced results from the Phase 3 trial comparing TV-46000/mdc-IRM once monthly (q1m) and TV-46000/mdc-IRM once every two months (q2m) with placebo
Five Considerations After Teva Pharmaceuticals' Q3 Report
05:09pm, Sunday, 31'st Oct 2021
TEVA stock is down irrationally after its quarterly earnings report. Shares traded at a 2021 forward P/E in the 3 times range.
Why Teva Pharmaceutical Industries Fell Today
06:01pm, Wednesday, 27'th Oct 2021
The pharmaceutical giant whiffs on both the top and bottom lines in its Q3.
We see a stable U.S. market place for our generics, says Teva Pharma CEO
03:28pm, Wednesday, 27'th Oct 2021
Meg Tirrell joins 'The Exchange' with Teva Pharmaceuticals CEO Kåre Schultz on the company's most recent earnings report and its guidance for the future.
Teva Pharmaceutical Industries Limited (TEVA) CEO Kare Schultz on Q3 2021 Results - Earnings Call Transcript
12:51pm, Wednesday, 27'th Oct 2021
Teva Pharmaceutical Industries Limited (TEVA) CEO Kare Schultz on Q3 2021 Results - Earnings Call Transcript
Teva Has Turned the Corner
12:10pm, Monday, 25'th Oct 2021
Shareholders of Teva Pharmaceutical Industries ( TEVA , Financial) thave now taken a multi-year beating. Since the company hit an all-time high in 2015 and bit off more than it can chew, over-paying f
Is Biogen stock a buy after Teva settled the Vumerity patent lawsuit?
02:57pm, Monday, 11'th Oct 2021
On Monday, Biogen Inc. (NASDAQ:BIIB) shares edged higher 1% after Teva Pharmaceutical Industries Ltd (TLV:TEVA) settled the Vumerity lawsuit. The lawsuit claimed that Teva's proposed generic version o
Teva Stops Production At U.S. Plant After FDA Concerns: Reports
12:24pm, Monday, 04'th Oct 2021
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has temporarily stopped drug production at its Irvine plant in California to address issues raised by the FDA after a recent inspection. The Company
Is A Fall Imminent For Teva Stock After Its Recent Rally?
07:00am, Friday, 01'st Oct 2021
The price of Teva Pharmaceutical stock has seen a rise of 14% in the last five trading days, while it is up 6% over the last month (twenty-one trading days). The recent rise came after the company ann
Why Teva Pharmaceutical Industries Shot Higher Today
04:34pm, Tuesday, 28'th Sep 2021
The company reached a settlement in a legal dispute with the state of Louisiana.
Is It Time to Buy Warren Buffett's Lowest-Priced Stock?
08:40am, Wednesday, 22'nd Sep 2021
Is Berkshire Hathaway's lowest per-share stock a buy?
Is Now the Time to Ditch Pharma Stocks?
06:45am, Tuesday, 21'st Sep 2021
With drug pricing reform on the horizon, investors may want to analyze their allocation.
5 Berkshire Hathaway Stocks in Downtrends
03:00pm, Friday, 17'th Sep 2021
Not everything goes up all the time on Wall Street, and no one expects that. Buyers of value stocks typically are prepared to wait for the longer term to play out.
Teva: Cautiously Bullish On 5-Year Prospects
09:15am, Friday, 17'th Sep 2021
Teva has faced scandal after scandal which soured investors and the general public alike. Even though I think the $40.5 billion Actavis acquisition was a good move, it leveraged Teva to uncomfortable
3 Discounted Buffett Stocks to Buy Hand Over Fist in September
05:51am, Wednesday, 08'th Sep 2021
Riding the Oracle of Omaha's coattails has historically been a smart move for investors.
